PAC Partners Equity Research has released its latest research and valuation report on Anatara Lifesciences (ASX:ANR). The report provided a BUY rating and a 12-month price target of $1.40 per share.
Pitt Street Research has released its latest initiating research and valuation report on Anatara Lifesciences (ASX:ANR). The report provides a $1.34 per share base case and a $3.61 optimistic case using a probability-weighted DCF valuation approach.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides an update on valuation of its investment portfolio.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides an update on recent events in the MMJ investment portfolio.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is holding a shareholders' meeting on 22 February 2019 to approve, amongst other matters, an equity raising pursuant to a share purchase plan.
MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is delighted to note that Fire & Flower Inc. (CVE:FAF) listed on the TSX Venture Exchange with its shares closing at CAD1.34 compared to MMJ's entry cost of CAD0.80.
Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4D financial report for the half year ending 31st December 2018.
